Jonathan Nash, MD, joined M Ventures in July 2021 and is currently an Associate in the Biotechnology team, focusing on investments for Healthcare and Life Sciences. Prior to joining M Ventures, Jonathan was an Associate at UBS within the Healthcare Investment Banking group in London. At UBS, he advised on a number of M&A and capital market transactions, including equity offerings for BioNTech and CureVac, among others. Prior to this, he was a Life Science Specialist at L.E.K. Consulting where he advised on strategy and due diligence projects for biopharma clients. Jonathan started his career as a Doctor in London and holds a Medical Degree and BSc from Imperial College. He is based in Amsterdam.